Chemoinformaics analysis of (4-PROPAN-2-YLPHENYL)METHANOL
| Molecular Weight | 150.221 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 0 |
| Exact Molecular Weight | 150.104 | nRing | 1 |
| Solubility: LogS | -4.382 | nHRing | 0 |
| Solubility: LogP | 4.631 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 1 | BPOL | 14.0449 |
| QED | 0.544 |
| Synth | 2.439 |
| Natural Product Likeliness | 1.283 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.268 |
| MDCK | 0.0000169 |
| BBB | 0.588 |
| PPB | 0.96366 |
| VDSS | 1.642 |
| FU | 0.0283358 |
| CYP1A2-inh | 0.889 |
| CYP1A2-sub | 0.534 |
| CYP2c19-inh | 0.344 |
| CYP2c19-sub | 0.309 |
| CYP2c9-inh | 0.313 |
| CYP2c9-sub | 0.595 |
| CYP2d6-inh | 0.135 |
| CYP2d6-sub | 0.209 |
| CYP3a4-inh | 0.187 |
| CYP3a4-sub | 0.108 |
| CL | 7.333 |
| T12 | 0.39 |
| hERG | 0.088 |
| Ames | 0.006 |
| ROA | 0.021 |
| SkinSen | 0.904 |
| Carcinogencity | 0.045 |
| EI | 0.98 |
| Respiratory | 0.358 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.90455 |